AXGN

#2056
Axogen, Inc. Common Stock
34.4600 USD
+2.96%
セクター: ヘルスケア
ベース: USD
利益通貨: USD
日中レンジ
34.4600
34.4600
1年のレンジ
17.1400
35.9999
1日の変化
+2.96%
月次変化
+5.03%
6か月変化
+88.93%
1年の変化
+88.93%
以前の終値
33.4700
始値
34.4600
Bid
Ask
安値
34.4600
High
34.4600
ボリューム
111
チャート全体を表示

Financials

概要 明細書 統計 配当金
期次 年次
  • Market Capitalization 1.7884 B
  • Employee 622
  • Founded 2002
  • CEO N/A
  • Website www.axogeninc.com
  • Headquarter Minnesota, United States
  • FIGI BBG000BN46R9
  • Industry Technology
総売上高
当期純利益
1株当たり基本利益（基本EPS）
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-96.26
売上高対価格比率
6.69

Axogen Inc

Axogen is a developer of surgical solutions, including human tissue grafts, based in Alachua, Florida. Axogen products are designed to remedy peripheral nerve damage. In 2013 the company raised $18 million in its initial public offering. Axogen uses a cell graft technology AVANCE to mimic a human nerve. The company also creates nerve connectors and soft tissue membranes. The company reports sensory and movement recovery in 87 percent of patients with peripheral nerve injuries. Axogen is part of the Sid Martin Biotechnology Incubator. As of 2019, Axogen was the only commercially available allograft approved by the Food and Drug Administration for clinical use.

ニュース